Prostate Cancer Trial, Recruiting NCT07463833 Sponsor: UNC Lineberger Comprehensive Cancer Center Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT07463833
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For healthcare providers:

  • Providers who are 18 years of age or older
  • Providers who attend peer-review meetings at the clinics taking part in the trial

For patients:

  • Patients who are 18 years of age or older
  • Patients with prostate cancer who are receiving radiation therapy treatment at one of the participating clinics (note: no treatment or intervention is delivered to patients as part of this trial)

Who may not be able to join:

For healthcare providers:

  • Providers who are unwilling or unable to follow the study procedures, or whose clinic is unable to put the required workflow in place or collect the needed results

For both patients and providers:

  • People who have dementia, a significantly altered mental state, or a psychiatric or other medical condition that would prevent them from understanding and agreeing to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lukasz Mazur, PhD, UNC Lineberger Comprehensive Cancer Center

Phone: (984) 974-8441

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
UNC Lineberger Comprehensive Cancer Center
Registry
ClinicalTrials.gov
Start date
22 June 2026
Est. completion
1 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of patients with changes nodal volume contours

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov